About Clinical Trials
Treatment trials test new treatments (like a new cancer drug, new approaches to surgery or radiation
therapy, new combinations of treatments, or new methods such as
gene therapy).
Prevention trials test new approaches,
such as medicines, vitamins, minerals, or other supplements that
doctors believe may lower the risk of a certain type of cancer.
These trials look for the best way to prevent cancer in people
who have never had cancer or to prevent cancer from coming back
or a new cancer occuring in people who have already had cancer.
Screening trials test the best way
to find cancer, especially in its early stages.
Quality of Life trials (also called
Supportive Care trials) explore ways to improve comfort and quality
of life for cancer patients.
Most clinical research that involves the testing of a new drug
progresses in an orderly series of steps, called phases. This allows
researchers to ask and answer questions in a way that results in
reliable information about the drug and protects the patients. Clinical
trials are usually classified into one of three phases:
Phase I trials: These first studies in people evaluate how a new
drug should be given (by mouth, injected into the blood, or injected
into the muscle), how often, and what dose is safe. A phase I trial
usually enrolls only a small number of patients, sometimes as few
as a dozen.
Phase II trials: A phase II trial continues to test the safety of
the drug, and begins to evaluate how well the new drug works. Phase
II studies usually focus on a particular type of cancer.
Phase III trials: These studies test a new drug, a new combination
of drugs, or a new surgical procedure in comparison to the current
standard. A participant will usually be assigned to the standard
group or the new group at random (called randomization). Phase III
trials often enroll large numbers of people and may be conducted
at many doctors' offices, clinics, and cancer centers nationwide.
Source: National Cancer Institute